We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.2B
AUM Growth
+$3.24B
(+7.1%)
Cap. Flow
+$512M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
15.87%
Holding
2,920
New
16
Increased
1,206
Reduced
1,586
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$23.3M |
| 2 |
Becton Dickinson
BDX
|
+$18.4M |
| 3 |
Amazon
AMZN
|
+$16.1M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$15.4M |
| 5 |
Johnson & Johnson
JNJ
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$48.1M |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$27.7M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
+$10.7M |
| 4 |
PRXL
Parexel International Corp
PRXL
|
+$10.3M |
| 5 |
CELG
Celgene Corp
CELG
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.9% |
| 2 | Technology | 16.24% |
| 3 | Healthcare | 13.01% |
| 4 | Industrials | 10.83% |
| 5 | Consumer Discretionary | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Photronics
PLAB
$1.79B
| $1.38M | ﹤0.01% |
161,980
+74,770
| +86% | +$683K |
|
|
VIVO
1802
DELISTED
Meridian Bioscience Inc
VIVO
| $1.38M | ﹤0.01% |
98,554
+13,491
| +16% | +$197K |
|
1803
Caesars Entertainment
CZR
$6.06B
| $1.38M | ﹤0.01% |
41,490
-7,937
| -16% | -$231K |
|
|
DYN
1804
DELISTED
Dynegy, Inc.
DYN
| $1.37M | ﹤0.01% |
115,746
-21,424
| -16% | -$239K |
|
1805
TTEC Holdings
TTEC
$121M
| $1.37M | ﹤0.01% |
34,060
+3,687
| +12% | +$152K |
|
|
FFG
1806
DELISTED
FBL Financial Group
FFG
| $1.37M | ﹤0.01% |
19,684
-2,545
| -11% | -$189K |
|
1807
MYR Group
MYRG
$5.19B
| $1.37M | ﹤0.01% |
38,238
+5,688
| +17% | +$189K |
|
1808
Hackett Group
HCKT
$270M
| $1.36M | ﹤0.01% |
86,881
-11,030
| -11% | -$171K |
|
1809
CorVel
CRVL
$3.06B
| $1.36M | ﹤0.01% |
77,265
+9,912
| +15% | +$187K |
|
|
RXDX
1810
DELISTED
Ignyta, Inc.
RXDX
| $1.36M | ﹤0.01% |
50,985
-2,994
| -6% | -$48.6K |
|
1811
Lantheus
LNTH
$6.49B
| $1.36M | ﹤0.01% |
66,381
+12,679
| +24% | +$258K |
|
1812
1st Source
SRCE
$2.16B
| $1.35M | ﹤0.01% |
27,361
-2,921
| -10% | -$148K |
|
1813
Regis Corp
RGS
$68.4M
| $1.34M | ﹤0.01% |
4,377
+518
| +13% | +$159K |
|
|
TAHO
1814
DELISTED
Tahoe Resources Inc
TAHO
| $1.34M | ﹤0.01% |
279,659
-1,889
| -0.7% | -$8.88K |
|
|
ONCE
1815
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.34M | ﹤0.01% |
26,038
-4,352
| -14% | -$313K |
|
1816
First Busey Corp
BUSE
$2.57B
| $1.34M | ﹤0.01% |
44,691
-5,983
| -12% | -$186K |
|
|
GTT
1817
DELISTED
GTT Communications, Inc.
GTT
| $1.34M | ﹤0.01% |
28,476
-5,534
| -16% | -$211K |
|
1818
HealthStream
HSTM
$819M
| $1.33M | ﹤0.01% |
57,608
+8,744
| +18% | +$206K |
|
|
ATSG
1819
DELISTED
Air Transport Services Group
ATSG
| $1.33M | ﹤0.01% |
57,499
-7,028
| -11% | -$168K |
|
1820
Lakeland Financial Corp
LKFN
$1.56B
| $1.33M | ﹤0.01% |
27,412
-4,880
| -15% | -$239K |
|
1821
Upbound Group
UPBD
$1.13B
| $1.32M | ﹤0.01% |
119,355
+18,822
| +19% | +$206K |
|
1822
American Vanguard Corp
AVD
$68.4M
| $1.32M | ﹤0.01% |
67,360
+8,093
| +14% | +$168K |
|
|
CUTR
1823
DELISTED
Cutera, Inc.
CUTR
| $1.32M | ﹤0.01% |
29,170
+15,300
| +110% | +$645K |
|
1824
Kearny Financial
KRNY
$604M
| $1.31M | ﹤0.01% |
90,941
-16,083
| -15% | -$239K |
|
|
WSR
1825
DELISTED
Whitestone REIT
WSR
| $1.31M | ﹤0.01% |
91,169
+11,328
| +14% | +$160K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, RhumbLine Advisers held 2,920 positions worth $49.2B, up 7.1% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2017: portfolio turnover was 3.5%. RhumbLine Advisers opened 16 new positions and exited 85, leaving the 2,920-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 187,382 shares worth $9.83M.
- RhumbLine Advisers added most to Microsoft in Q4 2017, an estimated $23.3M increase.
- RhumbLine Advisers's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.2M.
- RhumbLine Advisers fully exited CR Bard Inc. in Q4 2017, selling an estimated $48.1M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $49.2B portfolio in Q4 2017.
- RhumbLine Advisers opened 16 new positions and closed 85 in Q4 2017.
- RhumbLine Advisers's portfolio value rose 7.1% quarter-over-quarter to $49.2B.
Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.